Literature DB >> 16580828

Are mouse models of allergic asthma useful for testing novel therapeutics?

Michelle M Epstein1.   

Abstract

Experimental mouse allergic asthma is a reliable, clinically relevant facsimile of human disease. The focus here is to demonstrate that antigen-induced mouse allergic asthma is a useful model for testing novel therapeutics. Furthermore, it is especially crucial to treat mice during established disease, either during ongoing clinically manifest disease or to prevent disease relapses. In addition, our results indicate that lung Th2 resting memory cells are important targets for the treatment of allergic asthma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580828     DOI: 10.1016/j.etp.2006.02.005

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  3 in total

1.  Mimotope vaccination for therapy of allergic asthma: anti-inflammatory effects in a mouse model.

Authors:  J Wallmann; M M Epstein; P Singh; R Brunner; K Szalai; L El-Housseiny; I Pali-Schöll; E Jensen-Jarolim
Journal:  Clin Exp Allergy       Date:  2009-12-02       Impact factor: 5.018

2.  Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation.

Authors:  Ines Lindner; Christiane Meier; Angelika Url; Hermann Unger; Andreas Grassauer; Eva Prieschl-Grassauer; Petra Doerfler
Journal:  BMC Immunol       Date:  2010-05-21       Impact factor: 3.615

3.  Peripheral erythrocytes decrease upon specific respiratory challenge with grass pollen allergen in sensitized mice and in human subjects.

Authors:  Galateja Jordakieva; Julia Wallmann; René Schmutz; Patrick Lemell; Michael Wegmann; Thomas Nittke; Martina Mittlböck; Heinz Fehrenbach; Jasminka Godnic-Cvar; René Zieglmayer; Erika Jensen-Jarolim
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.